These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7508045)

  • 1. Vascular renin-angiotensin system and vascular protection.
    Dzau VJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ
    Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
    Dzau VJ; Gibbons GH; Pratt RE
    Hypertension; 1991 Oct; 18(4 Suppl):II100-5. PubMed ID: 1916996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue angiotensin generation and regulation of vascular tone.
    Cockcroft JR; O'Kane KP; Webb DJ
    Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
    Roks A; Buikema H; Pinto YM; van Gilst WH
    Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system and vascular hypertrophy.
    Rosendorff C
    J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of aortic smooth muscle cells and renin-angiotensin system in SHR rats.
    Wang XY; Wu KG; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):136-40. PubMed ID: 10374636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.
    Pratt RE; Dzau VJ
    Circulation; 1996 Mar; 93(5):848-52. PubMed ID: 8598073
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the tissue renin-angiotensin system in vascular remodeling and smooth muscle cell growth.
    Naftilan AJ
    Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):218-27. PubMed ID: 7842273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of the vascular renin-angiotensin system.
    Samani NJ; Swales JD
    Blood Vessels; 1991; 28(1-3):210-6. PubMed ID: 1848124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
    Paul M; Ganten D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S51-8. PubMed ID: 1381795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ACE inhibitors on coronary atherosclerosis and restenosis.
    Timmis AD; Pitt B
    Br Heart J; 1994 Sep; 72(3 Suppl):S57-60. PubMed ID: 7946805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.